Related references
Note: Only part of the references are listed.Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
B. C. V. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial
Nicola Logallo et al.
LANCET NEUROLOGY (2017)
Large-Vessel Occlusion Is Associated with Poor Outcome in Stroke Patients Aged 80 Years or Older Who Underwent Intravenous Thrombolysis
Wusheng Zhu et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2016)
The impact of intravenous thrombolysis on outcome of patients with acute ischemic stroke after 90 years old
S. Sagnier et al.
BMC GERIATRICS (2016)
Large-Vessel Occlusion Is Associated with Poor Outcome in Stroke Patients Aged 80 Years or Older Who Underwent Intravenous Thrombolysis
Wusheng Zhu et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2016)
Therapeutic Potential of Tenecteplase in the Management of Acute Ischemic Stroke
Nicola Logallo et al.
CNS DRUGS (2015)
The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
Nicola Logallo et al.
BMC NEUROLOGY (2014)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson et al.
LANCET (2014)
Stroke thrombolysis in England: an age stratified analysis of practice and outcome
Benjamin D. Bray et al.
AGE AND AGEING (2013)
Age over 80 years is not associated with increased hemorrhagic transformation after stroke thrombolysis
C. A. Costello et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Intravenous thrombolysis for acute cerebral ischaemia in old stroke patients ≥80 years of age
Gregoire Boulouis et al.
JOURNAL OF NEUROLOGY (2012)
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Peter Sandercock et al.
LANCET (2012)
Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis
Joanna M. Wardlaw et al.
LANCET (2012)
Outcome of Acute Ischemic Stroke in Very Elderly Patients: Is Intravenous Thrombolysis Beneficial?
Pi-Shan Sung et al.
EUROPEAN NEUROLOGY (2011)
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 - The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee
Werner Hacke et al.
CEREBROVASCULAR DISEASES (2008)
Older Age Does Not Increase Risk of Hemorrhagic Complications after Intravenous and/or Intra-Arterial Thrombolysis for Acute Stroke
Svetlna Pundik et al.
Journal of Stroke & Cerebrovascular Diseases (2008)
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
Werner Hacke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Share Paper
